REFERENCES
1. Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the
management of atrial fibrillation developed in collaboration with EACTS.Eur Heart J . 2016;37(38):2893-2962. doi:10.1093/eurheartj/ehw210
2. Wang TJ, Larson MG, Levy D, et al. Temporal relations of atrial
fibrillation and congestive heart failure and their joint influence on
mortality: the Framingham Heart Study. Circulation .
2003;107(23):2920-2925. doi:10.1161/01.CIR.0000072767.89944.6E
3. Khan MN, Jaïs P, Cummings J, et al. Pulmonary-vein isolation for
atrial fibrillation in patients with heart failure. N Engl J Med .
2008;359(17):1778-1785. doi:10.1056/NEJMoa0708234
4. Hunter RJ, Berriman TJ, Diab I, et al. A randomized controlled trial
of catheter ablation versus medical treatment of atrial fibrillation in
heart failure (the CAMTAF trial). Circ Arrhythm Electrophysiol .
2014;7(1):31-38. doi:10.1161/CIRCEP.113.000806
5. Di Biase L, Mohanty P, Mohanty S, et al. Ablation Versus Amiodarone
for Treatment of Persistent Atrial Fibrillation in Patients With
Congestive Heart Failure and an Implanted Device: Results From the AATAC
Multicenter Randomized Trial. Circulation .
2016;133(17):1637-1644. doi:10.1161/CIRCULATIONAHA.115.019406
6. Marrouche NF, Brachmann J, Andresen D, et al. Catheter Ablation for
Atrial Fibrillation with Heart Failure. N Engl J Med .
2018;378(5):417-427. doi:10.1056/NEJMoa1707855
7. Cha YM, Wokhlu A, Asirvatham SJ, et al. Success of ablation for
atrial fibrillation in isolated left ventricular diastolic dysfunction:
a comparison to systolic dysfunction and normal ventricular function.Circ Arrhythm Electrophysiol . 2011;4(5):724-732.
doi:10.1161/CIRCEP.110.960690
8. Machino-Ohtsuka T, Seo Y, Ishizu T, et al. Efficacy, safety, and
outcomes of catheter ablation of atrial fibrillation in patients with
heart failure with preserved ejection fraction. J Am Coll
Cardiol . 2013;62(20):1857-1865. doi:10.1016/j.jacc.2013.07.020
9. Chen MS, Marrouche NF, Khaykin Y, et al. Pulmonary vein isolation for
the treatment of atrial fibrillation in patients with impaired systolic
function. J Am Coll Cardiol . 2004;43(6):1004-1009.
doi:10.1016/j.jacc.2003.09.056
10. Sohns C, Saguner AM, Lemes C, et al. First clinical experience using
a novel high-resolution electroanatomical mapping system for left atrial
ablation procedures. Clin Res Cardiol . 2016;105(12):992-1002.
doi:10.1007/s00392-016-1008-7
11. Schaeffer B, Hoffmann BA, Meyer C, et al. Characterization, Mapping,
and Ablation of Complex Atrial Tachycardia: Initial Experience With a
Novel Method of Ultra High-Density 3D Mapping. J Cardiovasc
Electrophysiol . 2016;27(10):1139-1150. doi:10.1111/jce.13035
12. Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the
diagnosis and management of atrial fibrillation developed in
collaboration with the European Association for Cardio-Thoracic Surgery
(EACTS): The Task Force for the diagnosis and management of atrial
fibrillation of the European Society of Cardiology (ESC) Developed with
the special contribution of the European Heart Rhythm Association (EHRA)
of the ESC. Eur Heart J . 2021;42(5):373-498.
doi:10.1093/eurheartj/ehaa612
13. Lutomsky BA, Rostock T, Koops A, et al. Catheter ablation of
paroxysmal atrial fibrillation improves cardiac function: a prospective
study on the impact of atrial fibrillation ablation on left ventricular
function assessed by magnetic resonance imaging. Europace .
2008;10(5):593-599. doi:10.1093/europace/eun076
14. Ullah W, Ling LH, Prabhu S, et al. Catheter ablation of atrial
fibrillation in patients with heart failure: impact of maintaining sinus
rhythm on heart failure status and long-term rates of stroke and death.Europace . 2016;18(5):679-686. doi:10.1093/europace/euv440
15. Black-Maier E, Ren X, Steinberg BA, et al. Catheter ablation of
atrial fibrillation in patients with heart failure and preserved
ejection fraction. Heart Rhythm . 2018;15(5):651-657.
doi:10.1016/j.hrthm.2017.12.001
16. Yang PS, Park YA, Kim TH, et al. Which patients recur as atrial
tachycardia rather than atrial fibrillation after catheter ablation of
atrial fibrillation? PLoS ONE . 2017;12(11):e0188326.
doi:10.1371/journal.pone.0188326
17. Diamant MJ, Andrade JG, Virani SA, Jhund PS, Petrie MC, Hawkins NM.
Heart failure and atrial flutter: a systematic review of current
knowledge and practices. ESC Heart Fail . 2021;8(6):4484-4496.
doi:10.1002/ehf2.13526
18. Takigawa M, Derval N, Frontera A, et al. Revisiting anatomic
macroreentrant tachycardia after atrial fibrillation ablation using
ultrahigh-resolution mapping: Implications for ablation. Heart
Rhythm . 2018;15(3):326-333. doi:10.1016/j.hrthm.2017.10.029
19. Kitamura T, Martin R, Denis A, et al. Characteristics of Single-Loop
Macroreentrant Biatrial Tachycardia Diagnosed by Ultrahigh-Resolution
Mapping System. Circ Arrhythm Electrophysiol . 2018;11(2):e005558.
doi:10.1161/CIRCEP.117.005558
20. Providencia R, Elliott P, Patel K, et al. Catheter ablation for
atrial fibrillation in hypertrophic cardiomyopathy: a systematic review
and meta-analysis. Heart . 2016;102(19):1533-1543.
doi:10.1136/heartjnl-2016-309406
21. Hindricks G, Weiner S, McElderry T, et al. Acute safety,
effectiveness, and real-world clinical usage of ultra-high density
mapping for ablation of cardiac arrhythmias: results of the TRUE HD
study. Europace . 2019;21(4):655-661. doi:10.1093/europace/euy191